The FDA today approved lesinurad (Zurampic, AstraZeneca Pharmaceuticals) to treat hyperuricemia associated with gout, when used in combination with a xanthine oxidase inhibitor (XOI), a type of drug that reduces the production of uric acid in the body.
Gout is a painful form of arthritis caused by the buildup of too much uric acid in the body, and usually appears first as redness, soreness and swelling in the big toe. Uric acid in the blood is produced from the breakdown of purines, which